Year: 2021

Jennifer Sealey-Voyksner Special Guest for Beyond Celiac Blog Series

Read More

Latiglutenase development continues with initial CeliacShield™ study results and ongoing Solutions for Celiac™ clinical study actively recruiting participants

Read More

Significant Clinical Progress for Latiglutenase

Read More

ImmunogenX and Mayo Clinic Successfully Complete the CeliacShield Trial

Read More

Jennifer Sealey-Voyksner Chairs Session at Celiac Disease Foundation Summit

Read More

ImmunogenX Receives a Tibbetts Award

Read More

Matthew Dickason Featured on UC Irvine “Developing a Drug” Panel Discussion

Read More
Contact Us
ZymagenX
1600 Dove Street, Suite 330, Newport Beach, CA, 92660
Copyright © 2025 ZymagenX, Inc.